Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis
- PMID: 20499198
- PMCID: PMC2947648
- DOI: 10.1007/s11606-010-1375-0
Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis
Abstract
Objectives: There is controversy regarding the sensitivity of fecal occult blood tests (FOBT) for detecting colorectal cancer. Many of the published studies failed to correct for verification bias which may have increased the sensitivity.
Methods: A meta-analysis of published studies evaluating the sensitivity and specificity of chemical-based FOBT for colorectal cancer was performed. Studies were included if both cancer and control subjects underwent confirmatory testing. We also included studies that attempted to correct for verification bias by either performing colonoscopy on all subjects regardless of the FOBT result or by using longitudinal follow-up. We then compared the sensitivity, specificity, and other diagnostic characteristics of the studies that attempted to correct for verification (n=10) vs. those that did not correct for this bias (n=19).
Results: The pooled sensitivity of guaiac-based FOBT for colorectal cancer of studies without verification bias was significantly lower than those studies with this bias [0.36 (95% CI 0.25-0.47) vs. 0.70 (95% CI 0.60-0.80), p=0.001]. The pooled specificity of the studies without verification bias was higher [0.96 (95% CI 0.94-0.97) vs. 0.88 (95% CI 0.84-0.91), p<0.005]. There was no significant difference in the area under the summary receiver operating characteristic curves. More sensitive chemical-based FOBT methods (e.g., Hemoccult® SENSA®) had a higher sensitivity but a lower specificity than standard guaiac methods.
Conclusions: The sensitivity of guaiac-based FOBT for colorectal cancer has been overestimated as a result of verification bias. This test may not be sensitive enough to serve as an effective screening option for colorectal cancer.
Figures
Similar articles
-
A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 9. Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 9. PMID: 25905156 Free Books & Documents. Review.
-
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. doi: 10.1093/jnci/djm150. Epub 2007 Sep 25. J Natl Cancer Inst. 2007. PMID: 17895475
-
Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.Lancet Oncol. 2006 Feb;7(2):127-31. doi: 10.1016/S1470-2045(05)70473-3. Lancet Oncol. 2006. PMID: 16455476
-
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25. Gastroenterology. 2008. PMID: 18482589 Clinical Trial.
-
Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.Aliment Pharmacol Ther. 2016 Apr;43(7):755-64. doi: 10.1111/apt.13556. Epub 2016 Feb 9. Aliment Pharmacol Ther. 2016. PMID: 26858128 Review.
Cited by
-
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1517-1520. doi: 10.1158/1055-9965.EPI-22-0232. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35916602 Free PMC article.
-
Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.Gastroenterology. 2019 Dec;157(6):1494-1505. doi: 10.1053/j.gastro.2019.08.023. Epub 2019 Aug 22. Gastroenterology. 2019. PMID: 31472152 Free PMC article.
-
One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).J Am Soc Nephrol. 2019 Jun;30(6):1061-1072. doi: 10.1681/ASN.2018121232. Epub 2019 Apr 30. J Am Soc Nephrol. 2019. PMID: 31040191 Free PMC article.
-
Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening.Eur J Epidemiol. 2019 Feb;34(2):163-172. doi: 10.1007/s10654-018-0471-z. Epub 2018 Dec 8. Eur J Epidemiol. 2019. PMID: 30536183
-
Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.Ann Intern Med. 2018 Oct 2;169(7):439-447. doi: 10.7326/M18-0244. Epub 2018 Sep 18. Ann Intern Med. 2018. PMID: 30242328 Free PMC article.
References
-
- Centers for Disease Control and Prevention Use of colorectal cancer tests-United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57:253–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
